Claris Ventures SGR SpA makes equity investments in early stage biopharma companies with a clear vision and solid scientific evidence.
We are fascinated by science and we are committed to help the best innovators in addressing strong unmet clinical needs, spanning from rare diseases to oncology, immunology and other life threatening disease areas.
We provide capital, competence and hands-on support to jump start clinical development programs and pursue value creation based on clinical evidence.
Claris Biotech I is supported by InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing” (or the relevant translation).
Company Details
- Employees
- 14
- Founded
- -
- Address
- Turin, Turin 10122, It
- Phone
- +39 (0) 11 3325889
- in****@****res.com
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- clarisventures.com
- Keywords
- Venture Capital and Biotech.
- HQ
- Turin, Turin
Claris Ventures Questions
Claris Ventures's helpline number is +39 (0) 11 3325889
Claris Ventures's website is clarisventures.com
Claris Ventures's LinkedIn profile is https://it.linkedin.com/company/clarisventures
Claris Ventures has
14 employees.
View email and phone details for 14
employees at Claris Ventures.
Claris Ventures's industry is
Venture Capital and Private Equity Principals
Claris Ventures's top competitors are
Indaco Venture Partners,
Angelini Ventures,
Liftt,
Kither Biotech,
Cdp Venture Capital Sgr,
Resalis Therapeutics,
Innogest Capital,
Neva Sgr,
Panakes Partners,
Neophore Ltd.
Claris Ventures's support email address is info@clarisventures.com
Claris Ventures's categories are Venture Capital and Private Equity Principals
Claris Ventures's founding year is 2019
